Menu
GeneBe

rs565866662

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 0P and 0B.

The NM_183374.3(CYP26C1):c.845_851dup(p.Gln284HisfsTer129) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00248 in 1,613,456 control chromosomes in the GnomAD database, including 8 homozygotes. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Variant results in nonsense mediated mRNA decay.

Frequency

Genomes: 𝑓 0.0020 ( 1 hom., cov: 33)
Exomes 𝑓: 0.0025 ( 7 hom. )

Consequence

CYP26C1
NM_183374.3 frameshift

Scores

Not classified

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:3U:1B:2

Conservation

PhyloP100: 2.91
Variant links:
Genes affected
CYP26C1 (HGNC:20577): (cytochrome P450 family 26 subfamily C member 1) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This enzyme is involved in the catabolism of all-trans- and 9-cis-retinoic acid, and thus contributes to the regulation of retinoic acid levels in cells and tissues. This gene is adjacent to a related gene on chromosome 10q23.33. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
CYP26C1NM_183374.3 linkuse as main transcriptc.845_851dup p.Gln284HisfsTer129 frameshift_variant 4/6 ENST00000651965.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
CYP26C1ENST00000651965.1 linkuse as main transcriptc.845_851dup p.Gln284HisfsTer129 frameshift_variant 4/6 NM_183374.3 P1
CYP26C1ENST00000624358.3 linkuse as main transcriptc.*1117-63_*1117-57dup intron_variant, NMD_transcript_variant 2

Frequencies

GnomAD3 genomes
AF:
0.00204
AC:
311
AN:
152214
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000531
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000262
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00885
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00281
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.00211
AC:
529
AN:
250796
Hom.:
1
AF XY:
0.00218
AC XY:
295
AN XY:
135520
show subpopulations
Gnomad AFR exome
AF:
0.000554
Gnomad AMR exome
AF:
0.000174
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00716
Gnomad NFE exome
AF:
0.00305
Gnomad OTH exome
AF:
0.00213
GnomAD4 exome
AF:
0.00252
AC:
3688
AN:
1461124
Hom.:
7
Cov.:
30
AF XY:
0.00237
AC XY:
1719
AN XY:
726788
show subpopulations
Gnomad4 AFR exome
AF:
0.000269
Gnomad4 AMR exome
AF:
0.000179
Gnomad4 ASJ exome
AF:
0.000115
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00647
Gnomad4 NFE exome
AF:
0.00290
Gnomad4 OTH exome
AF:
0.00167
GnomAD4 genome
AF:
0.00204
AC:
311
AN:
152332
Hom.:
1
Cov.:
33
AF XY:
0.00236
AC XY:
176
AN XY:
74484
show subpopulations
Gnomad4 AFR
AF:
0.000529
Gnomad4 AMR
AF:
0.000262
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00885
Gnomad4 NFE
AF:
0.00281
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.00132
Hom.:
0
Bravo
AF:
0.00141

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:3Uncertain:1Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Pathogenic:2Benign:1
Pathogenic, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenMar 01, 2024CYP26C1: PVS1, PM2, PM3, PP4 -
Likely pathogenic, criteria provided, single submitterclinical testingGeneDxJun 20, 2023Published functional studies demonstrate a damaging effect with this variant demonstrating 4% of enzyme activity as compared to wild-type (Slavotinek et al., 2013); Frameshift variant predicted to result in protein truncation as the last 239 amino acids are replaced with 128 different amino acids, although loss-of-function variants have not been reported downstream of this position in the protein; This variant is associated with the following publications: (PMID: 23161670, 32040484, 34426522, 29263414) -
Likely benign, criteria provided, single submitterclinical testingInvitaeDec 31, 2019- -
Focal facial dermal dysplasia type IV Pathogenic:1
Pathogenic, no assertion criteria providedliterature onlyOMIMFeb 15, 2013- -
not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineNov 20, 2018Variant classified as Uncertain Significance - Favor Pathogenic. The p.Gln284His fsX129 variant in CYP26C1 has been reported in 3 homozygous and 2 compound heter ozygous individuals with focal facial dermal dysplasia 4 (FFDD 4)and segregated with disease in 1 affected relative (Slavotinek 2013, Lee 2018). This variant is predicted to cause a frameshift, which alters the protein?s amino acid sequence beginning at position 284 and leads to a premature termination codon 129 amino acids downstream. This termination codon occurs within the terminal 50 bases of the second to last exon and is, therefore, likely to escape nonsense mediated de cay (NMD) and result in a truncated protein. This variant has also been identifi ed in 0.7% (177/25112) of Finnish and 0.3% (392/128808) of European chromosomes by gnomAD (http://gnomad.broadinstitute.org), which is higher than expected cons idering the rarity of FFDD 4. It has been speculated that this is due to incompl ete penetrance or under ascertainment (Slavotinek 2013); however, it is unclear at this time. In summary, while there is some suspicion for a pathogenic role, t he clinical significance of the p.Gln284HisfsX129 variant is uncertain due to co nflicting data. ACMG/AMP Criteria applied: PM3, PM4, BS1_Supporting. -
Optic nerve hypoplasia Benign:1
Likely benign, criteria provided, single submitterresearchRare Disease Group, Clinical Genetics, Karolinska Institutet-- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs565866662; hg19: chr10-94824276; API